Dr. Mark Feinberg

Dr. Mark W. Feinberg is a Cardiologist at Brigham and Women’s Hospital (BWH) and an Associate Professor of Medicine at Harvard Medical School. In addition, he is an affiliated faculty member at the Harvard Stem Cell Institute. Dr. Feinberg directs an NIH-funded basic science laboratory that investigates mechanisms leading to the development of atherosclerosis (coronary artery disease) and myocardial infarction (heart attack). Dr. Feinberg has held various leadership roles in cardiovascular research including his service on national peer review study sections, editorial service, and as a Co-Chair of the Brigham Research Institute’s Cardiovascular, Diabetes, and Metabolic Disorders Center. He is passionate for translating biomedical discoveries into rationale therapies for biotech companies.

Dr. Feinberg received his medical degree from Medical College of Pennsylvania. Dr. Feinberg is a member of the American Society of Clinical Investigation and has received several major research awards including an AHA Louis N. and Arnold M. Katz Prize Finalist and the David W. Haack Memorial Award.